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2:15 p.m.
818-2 Vascular Access and Fluoroscopy in Percutaneous 
Coronary Interventions: A Quality Improvement Project
Peter VerLee, Patricia Hofmaster, Theodore Silver, Paul Vom Eigen, Matthew Rowe, 
Carol Gallupe, Winthrop Piper, David Malenka, Eastern Maine Medical Center, Bangor, 
ME, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Background: In previous work by the Northern New England Cardiovascular Study
Group risk factors for vascular access site complications in PCI were identified and a
region-wide effort to reduce these complications was initiated. As part of this effort we
considered making a regional recommendation that location of the femoral head as seen
on fluoroscopy (fluoro) be used to help determine the site of femoral artery puncture. To
assess the validity of such a practice guideline we assessed the use of fluoro guided vas-
cular access to determine whether it reduced the rate of vascular complications and
shortened length of stay.
Methods: Data was collected prospectively on 2,206 consecutive PCIs at Eastern Maine
Medical Center from 1999-2002 including use of fluoro, vascular access site complica-
tions (bleeding, pseudoaneurysm formation, hematoma, embolic event or thrombus, A-V
fistula), and length of stay.
Results: Use of fluoro among 7 interventionists was variable: 2 >20%, 3 35-45%, 2
>70%. Among all interventions, 46% were performed with fluoro to guide vascular
access. The use of fluoro was associated with a significantly lower incidence of artery
injury (0.59% v 1.51%, p=0.04. Among a subset of physicians (n=3) whose use of fluoro
was less frequent and variable (38%, 39%, 45%), there were fewer vascular injuries
among patients for whom fluoro guided vascular access (0.71% v 1.77%, p=0.14). Aver-
age length of stay was significantly lower among patients in the fluoro group ( 2.1 days
vs. 2.6, p=0.007).
Conclusion: We conclude that using fluoro to guide vascular access leads to lower com-
plication rates and a shorter length of stay and that this approach to femoral access
might reasonably become a regional standard of care. At Eastern Maine Medical Center
the current use of fluoro to guide vascular access now exceeds 70%.
2:30 p.m.
818-3 Declining Entry Site Complications After Percutaneous 
Coronary Interventions
Joseph Lindsay, Daniel A. Canos, Ellen Pinnow, Sue Apple, Peter C. Iloanya, Augusto D. 
Pichard, Washington Hospital Center, Washington, DC
Background: Outcomes of percutaneous coronary intervention (PCI) have improved
over the past decade. Angiographic success is now > 95% and urgent/emergent coro-
nary revascularization surgery <1%. These advances are due to operator experience,
new equipment, and the adoption of more effective antithrombotic strategies. Ineffective
or dangerous devices and anticoagulation strategies have been abandoned. Little infor-
mation is available about the effect of these changes on entry-site complications. Meth-
ods:We examined entry-site complications in 14,194 pts with PCI from 1991-2001 in our
laboratoy. The frequency of surgical repair (SR) and major bleeding, (drop in hematocrit
of >0.15) were the outcomes of interest. Results: The frequency of major bleeding
steadily decreased (7.6% in 1991 to 1.5% in 2001 (p for trend <0.001). This decline was
paralleled by a reduction in the need for SR (4.5% in 1993 to 1.2% in 2001, p for trend
<0.001). Declining use of warfarin anticoagulation, lower target ACT levels for heparin
dosing, and less frequent use of an intra-aortic balloon pump (IABP) likely helped reduce
the frequency of these events. The introduction of GP IIb/IIIa inhibitors (currently used in
50% of cases) and the potent antiplatelet agents (current use 96%) did not interrupt the
decline. Conclusions: In this single center experience the improved procedural out-
comes of PCI have been accompanied by a dramatic reduction in entry site complica-
tions. 
2:45 p.m.
818-4 Vascular Complications Associated With Arteriotomy 
Closure Devices in Patients Undergoing Percutaneous 
Coronary Procedures: A Meta-Analysis
Eugenia Nikolsky, Amir Halkin, Roxana Mehran, Shoshana R. Krieger, Eve A. Aymong, 
Zoran Lasic, Manuela Negoita, Ramez Sulaiman, Ricardo A. Costa, Jeffrey W. Moses, 
Gregg W. Stone, Martin B. Leon, George D. Dangas, The Cardiovascular Research 
Foundation and the Lenox Hill Heart and Vascular Institute, New York, NY
Background. Arteriotomy closure devices (ACD) are frequently used for hemostasis after
percutaneous endovascular procedures. To evaluate overall vascular complications asso-
ciated with ACD, we performed a meta-analysis of studies using ACD in pts undergoing
percutaneous transfemoral coronary procedures. Methods. Studies considered for meta-
analysis included randomized, case-control and cohort studies comparing vascular com-
plications in pts managed with ACD (AngioSeal, VasoSeal and Perclose) vs. mechanical
compression. Cumulative incidence of major vascular complications was the primary
endpoint defined as pseudoaneurysm, a-v fistula, retroperitoneal hematoma, femoral
artery thrombosis, surgical vascular repair, access site infection, and transfusion. Data
on diagnostic catheterization (Dx) and percutaneous coronary interventions (PCI) were
assessed separately and in combination. Heterogeneity between studies was assessed
using Cochran’s Q-statistic. Results. A total of 30 studies involving 42,253 pts fulfilled the
inclusion criteria. Comparing complication rates with ACD vs. mechanical compression is
shown in the Figure. Conclusions. In the setting of Dx angiography the risk of complica-
tions was similar with all 3 devices compared to mechanical compression. In the setting
of PCI, risk of vascular complications using AngioSeal and Perclose was similar to that of
mechanical compression while complications appeared higher with VasoSeal compared
to mechanical compression.
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